Abstract:Chronic kidney disease (CKD) inevitably progresses to end-stage renal disease if intervention does not occur timely. However, there are limitations in predicting the progression of CKD by solely relying on changes in renal function. A biomarker with high sensitivity and specificity that can predict CKD progression early is required. We used the online Gene Expression Omnibus microarray dataset GSE45980 to identify differentially expressed genes (DEGs) in patients with progressive and stable CKD. We then performed functional enrichment and protein-protein interaction network analysis on DEGs and identified key genes. Finally, the expression patterns of key genes were verified using the GSE60860 dataset, and the receiver operating characteristic curve analysis was performed to clarify their predictive ability of progressive CKD. Ultimately, we verified the expression profiles of these hub genes in an in vitro renal interstitial fibrosis model by real-time PCR and western blot analysis. Differential expression analysis identified 50 upregulated genes and 47 downregulated genes. The results of the functional enrichment analysis revealed that upregulated DEGs were mainly enriched in immune response, inflammatory response, and NF-κB signaling pathways, whereas downregulated DEGs were mainly related to angiogenesis and the extracellular environment. Protein-protein interaction network and key gene analysis identified CCR7 as the most important gene. CCR7 mainly plays a role in immune response, and its only receptors, CCL19 and CCL21, have also been identified as DEGs. The receiver operating characteristic curve analysis of CCR7, CCL19, and CCL21 found that CCR7 and CCL19 present good disease prediction ability. CCR7 may be a stable biomarker for predicting CKD progression, and the CCR7-CCL19/CCL21 axis may be a therapeutic target for end-stage renal disease. However, further experiments are needed to explore the relationship between these genes and CKD.

Screening for Proteins Interacting with Novel Gene Collectrin in Adult Human Kidney Cdna Library by Yeast Two Hybrid System

Study on Proteins Interacting with Angiotensin-(1-7) by Yeast Two-hybrid System

Identification and Localization of Human Collectrin in Normal Kidney

[Screening for Proteins Interacting with Novel Gene AngRem104 in the Adult Human Kidney Cdna Library by Yeast Two Hybrid System].

Research on Screening and Identification of Proteins Interacting with Ataxin-3.

Screening of Proteins Interacting with Gankyrin by Yeast Two-Hybrid in Human Breast cDNA Library

Screening of the interaction protein with Wnt signaling molecular-TCF4 from renal carcinoma cDNA library by yeast two hybrid

Screening of Proteins Interacting with CUEDC2 by Yeast Two Hybrid

Collectrin,a kidney-specific gene,is localized in collecting duct cells in kidney

Bioinformatics analysis reveals CCR7 as a potential biomarker for predicting CKD progression

Identification of Interacting Proteins with Gankyrin by Affinity Purification Technology

Yeast two-hybrid assay for screening proteins interacting with HCV NS4B in human leukocytes cDNA library

Plasma proteome analysis implicates novel proteins as potential therapeutic targets for chronic kidney disease: A proteome-wide association study

The Role for Hnf-1 Beta-Targeted Collectrin in Maintenance of Primary Cilia and Cell Polarity in Collecting Duct Cells

Interaction of novel gene AngRem104 and Bardet-Biedl syndrome 2 protein in mammalian cells

Yeast Two-Hybrid Screening for Proteins That Interact with Alpha(1)-Adrenergic Receptors

Isolation and cloning of 17 novel C2H2 zinc finger gene fragments

Identification of over-expressed genes in human renal cell carcinoma by combining suppression subtractive hybridization and cDNA library array

Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease

Use of Suppression Subtractive Hybridization Strategy for Cloning and Identifying Specifically Expressed Genes of Renal Cell Carcinoma

Identification of Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma.